Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Botensilimab + Balstilimab for Colorectal Cancer
Recruiting1 awardPhase 2
Durham, North Carolina
This trial will involve 15 patients with tumors who will undergo genetic testing before starting treatment with botensilimab and balstilimab. They will continue this treatment in 6-week cycles
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service